Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84


Modeling the effect of collagen fibril alignment on ligament mechanical behavior.

Stender CJ, Rust E, Martin PT, Neumann EE, Brown RJ, Lujan TJ.

Biomech Model Mechanobiol. 2018 Apr;17(2):543-557. doi: 10.1007/s10237-017-0977-4. Epub 2017 Nov 24.


Absorption, Distribution, Metabolism, and Excretion of [14C]-Volixibat in Healthy Men: Phase 1 Open-Label Study.

Siebers N, Palmer M, Silberg DG, Jennings L, Bliss C, Martin PT.

Eur J Drug Metab Pharmacokinet. 2018 Feb;43(1):91-101. doi: 10.1007/s13318-017-0429-7.


Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone.

Cramer ML, Shao G, Rodino-Klapac LR, Chicoine LG, Martin PT.

Hum Gene Ther. 2017 Jun;28(6):493-509. doi: 10.1089/hum.2016.113. Epub 2017 Mar 23.


Deletion of Pofut1 in Mouse Skeletal Myofibers Induces Muscle Aging-Related Phenotypes in cis and in trans.

Zygmunt DA, Singhal N, Kim ML, Cramer ML, Crowe KE, Xu R, Jia Y, Adair J, Martinez-Pena Y Valenzuela I, Akaaboune M, White P, Janssen PM, Martin PT.

Mol Cell Biol. 2017 May 2;37(10). pii: e00426-16. doi: 10.1128/MCB.00426-16. Print 2017 May 15.


Loss of CMAH during Human Evolution Primed the Monocyte-Macrophage Lineage toward a More Inflammatory and Phagocytic State.

Okerblom JJ, Schwarz F, Olson J, Fletes W, Ali SR, Martin PT, Glass CK, Nizet V, Varki A.

J Immunol. 2017 Mar 15;198(6):2366-2373. doi: 10.4049/jimmunol.1601471. Epub 2017 Feb 1.


Comparison of Serum rAAV Serotype-Specific Antibodies in Patients with Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Inclusion Body Myositis, or GNE Myopathy.

Zygmunt DA, Crowe KE, Flanigan KM, Martin PT.

Hum Gene Ther. 2017 Sep;28(9):737-746. doi: 10.1089/hum.2016.141. Epub 2016 Dec 29.


N-terminal α Dystroglycan (αDG-N): A Potential Serum Biomarker for Duchenne Muscular Dystrophy.

Crowe KE, Shao G, Flanigan KM, Martin PT.

J Neuromuscul Dis. 2016 May 27;3(2):247-260.


B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.

Thomas PJ, Xu R, Martin PT.

Am J Pathol. 2016 Sep;186(9):2429-48. doi: 10.1016/j.ajpath.2016.05.021.


A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function.

Ermer J, Corcoran M, Lasseter K, Marbury T, Yan B, Martin PT.

Ther Drug Monit. 2016 Aug;38(4):546-55. doi: 10.1097/FTD.0000000000000296.


Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.

Xu R, Singhal N, Serinagaoglu Y, Chandrasekharan K, Joshi M, Bauer JA, Janssen PM, Martin PT.

Am J Pathol. 2015 Oct;185(10):2668-84. doi: 10.1016/j.ajpath.2015.06.008.


A role for Galgt1 in skeletal muscle regeneration.

Singhal N, Martin PT.

Skelet Muscle. 2015 Jan 27;5:3. doi: 10.1186/s13395-014-0028-0. eCollection 2015.


A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.

Martin PT, Golden B, Okerblom J, Camboni M, Chandrasekharan K, Xu R, Varki A, Flanigan KM, Kornegay JN.

PLoS One. 2014 Feb 5;9(2):e88226. doi: 10.1371/journal.pone.0088226. eCollection 2014.


Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery.

Chicoine LG, Montgomery CL, Bremer WG, Shontz KM, Griffin DA, Heller KN, Lewis S, Malik V, Grose WE, Shilling CJ, Campbell KJ, Preston TJ, Coley BD, Martin PT, Walker CM, Clark KR, Sahenk Z, Mendell JR, Rodino-Klapac LR.

Mol Ther. 2014 Feb;22(2):338-347. doi: 10.1038/mt.2013.244. Epub 2013 Oct 23.


Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin α2 surrogates.

Chicoine LG, Rodino-Klapac LR, Shao G, Xu R, Bremer WG, Camboni M, Golden B, Montgomery CL, Shontz K, Heller KN, Griffin DA, Lewis S, Coley BD, Walker CM, Clark KR, Sahenk Z, Mendell JR, Martin PT.

Mol Ther. 2014 Apr;22(4):713-24. doi: 10.1038/mt.2013.246. Epub 2013 Oct 22.


Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease.

Camboni M, Wang CM, Miranda C, Yoon JH, Xu R, Zygmunt D, Kaspar BK, Martin PT.

Neurobiol Dis. 2014 Feb;62:31-43. doi: 10.1016/j.nbd.2013.09.001. Epub 2013 Sep 8.


Identification of new dystroglycan complexes in skeletal muscle.

Johnson EK, Li B, Yoon JH, Flanigan KM, Martin PT, Ervasti J, Montanaro F.

PLoS One. 2013 Aug 8;8(8):e73224. doi: 10.1371/journal.pone.0073224. eCollection 2013.


N-Glycolylneuraminic acid deficiency worsens cardiac and skeletal muscle pathophysiology in α-sarcoglycan-deficient mice.

Martin PT, Camboni M, Xu R, Golden B, Chandrasekharan K, Wang CM, Varki A, Janssen PM.

Glycobiology. 2013 Jul;23(7):833-43. doi: 10.1093/glycob/cwt020. Epub 2013 Mar 20.


Distinct contributions of Galgt1 and Galgt2 to carbohydrate expression and function at the mouse neuromuscular junction.

Singhal N, Xu R, Martin PT.

Mol Cell Neurosci. 2012 Nov;51(3-4):112-26. doi: 10.1016/j.mcn.2012.08.014. Epub 2012 Sep 7.

Supplemental Content

Loading ...
Support Center